Like MedAware Systems, Inc.

announced 9/16/2022 via BNC Analysis

Biomed Industries, Inc., will acquire MedAware Systems, Inc.

synopsis: Biomed Industries, a bio-pharmaceutical company, will acquire MedAware Systems, a next generation medical research data company. MedAware empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
buyer: Biomed Industries, Inc.
Biomed Industries is a bio-pharmaceutical company committed to the development and commercialization of new drug therapeutics for unmet needs. Biomed develops pharmaceutical products for malaria and various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's Disease, and more. "
target: MedAware Systems, Inc.
MedAware Systems is a next generation medical research data company. MedAware Systems empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/11/2019 via PR Newswire

Corrona, Inc., acquired HealthiVibe LLC

synopsis: Corrona, LLC, a leading provider of real-world observational and syndicated registry data, announced that it has acquired HealthiVibe, LLC, a leading patient experience company. HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle.
buyer parent: Great Point Partners
buyer: Corrona, Inc.
Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. "
target: HealthiVibe LLC
HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle. They leverage models and online analytic platforms to provide tools to optimize clinical trials and enhance product commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 5/5/2010 via Company Press Release

Kenneth Getz, acquired CenterWatch, Inc.

synopsis: Ken Getz, the founder of CenterWatch—an industry-leading clinical trials information services company—along with private equity investors has purchased the company from Jobson Medical Information.
buyer: Kenneth Getz
Ken Getz founded CenterWatch in 1994 and established the company as a leading provider of operating and business information on the $40 billion global clinical trials industry. Getz sold the company to the Thomson Corporation in 1998. "
target parent: Wicks Group of Companies
target: CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/31/2007 via Berkery

Jobson Medical Information LLC, acquired CenterWatch, Inc.

synopsis: The Thomson Corporation announced the sale of CenterWatch to Jobson Medical Information, a portfolio company of The Wicks Group, LLC. CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
buyer parent: The Wicks Group of Companies, L.L.C.
buyer: Jobson Medical Information LLC
Jobson Medical Information is a leading specialty healthcare communications, publishing, and medical education company. Jobson Medical Information produces a broad range of publications, educational programs, enduring educational materials, live events, symposia and websites. "
target parent: Thomson Corporation
target: CenterWatch, Inc.
CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2019 via BNC Analysis

Genstar Capital LLC, acquired Advarra

synopsis: Genstar Capital, a private equity firm focused on investments in financial services, healthcare, industrial technology, and software industries, has acquired Advarra, a leading provider of institutional review board, institutional biosafety committee, and research quality and compliance solutions that are critical to the drug development process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that actively invests in high quality companies. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. "
target parent: Linden Capital Partners
target: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/9/2021 via Company Press Release

Telstra Health, will acquire MedicalDirector

synopsis: Telstra announced that Telstra Health has entered into a binding agreement to acquire leading GP clinical and practice management software company MedicalDirector. MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is Australia's largest ehealth company. Telstra Health provides technology solutions that help improve the quality, efficiency and security of health services. They offer products and solutions for electronic medical records, telehealth, back office, medication management and more. "
target parent: Affinity Equity Partners
target: MedicalDirector
MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, and clinical content.
price ($mm)
$257
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2016 via BNC Analysis

Affinity Equity Partners, acquired MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners has acquired Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 9/16/2022 via BNC Analysis

Biomed Industries, Inc., will acquire MedAware Systems, Inc.

synopsis: Biomed Industries, a bio-pharmaceutical company, will acquire MedAware Systems, a next generation medical research data company. MedAware empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
buyer: Biomed Industries, Inc.
Biomed Industries is a bio-pharmaceutical company committed to the development and commercialization of new drug therapeutics for unmet needs. Biomed develops pharmaceutical products for malaria and various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's Disease, and more. "
target: MedAware Systems, Inc.
MedAware Systems is a next generation medical research data company. MedAware Systems empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/16/2022 via BNC Analysis

Biomed Industries, Inc., will acquire MedAware Systems, Inc.

synopsis: Biomed Industries, a bio-pharmaceutical company, will acquire MedAware Systems, a next generation medical research data company. MedAware empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
buyer: Biomed Industries, Inc.
Biomed Industries is a bio-pharmaceutical company committed to the development and commercialization of new drug therapeutics for unmet needs. Biomed develops pharmaceutical products for malaria and various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's Disease, and more. "
target: MedAware Systems, Inc.
MedAware Systems is a next generation medical research data company. MedAware Systems empowers pharma and medical device companies with all available evidence from published clinical trials research. Their platform delivers detailed data from published literature and reported regulatory events.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via GlobeNewswire

Syneos Health, acquired StudyKIK

synopsis: Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
buyer: Syneos Health (INCR:$5,418.61)
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. "
target: StudyKIK
StudyKIK is a leading technology-enabled clinical trial recruitment and retention company. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2022 via Company Press Release

EMIS Group, acquired FourteenFish Ltd

synopsis: EMIS Group, a British leader in clinical IT software for joined-up patient care, has acquired medical appraisals specialist FourteenFish. Based in the UK, FourteenFish supports over 100,000 healthcare professionals – including GPs, nurses and practice managers – with their continued professional development (CPD) and ongoing industry learning.
buyer: EMIS Group (AIM:EMIS:$221.66)
EMIS Group is a British leader in clinical IT software for joined-up patient care, supplying essential technology to 10,000 healthcare organisations across every major UK health sector. "
target: FourteenFish Ltd
FourteenFish Ltd is a UK-based company specialising in medical appraisals. FourteenFish supports over 100,000 healthcare professionals – including GPs, nurses and practice managers – with their continued professional development (CPD) and ongoing industry learning.
price ($mm)
$21
rev ($mm)
$3
EBITDA ($mm)
EV / rev
6.6x
EV / EBITDA
closed 7/20/2020 via BNC Analysis

Carepointe merged with US Health Systems,

synopsis: Carepointe, a healthcare technology company whose cloud-based payment systems focus on managed and value-based care, has merged with US Health Systems (USHS), a value-based population health management company. The merger of Carepointe and USHS will create Arkos Health, and they will operate as subsidiaries of the new company.
buyer: US Health Systems
US Health Systems (USHS) is a value-based population health management company. USHS processes often stop the complex cycle of patients returning to acute facilities or emergency rooms and allow the patient to remain or return to their medical home with primary care or advanced primary care. "
target parent: OnPointe
target: Carepointe
Carepointe technology solves the tough challenges of managing complex populations and integrating health service delivery. CarePointe's cloud-based payment systems focus on managed care and value-based care and have 2,500 providers across the country.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2019 via BusinessWire

Regroup Telehealth Inc. merged with InSight Telepsychiatry,

synopsis: InSight Telepsychiatry and Regroup Telehealth have merged to become the largest and most comprehensive telepsychiatry service provider in the US. The merger brings together a robust network of providers and a group of clinical and executive leaders with extensive experience and expertise for underserved individuals and communities.
buyer parent: Harbour Point Capital
buyer: InSight Telepsychiatry
InSight is the leading national telepsychiatry service provider increasing access to quality behavioral health care through applications of technology. InSight serves hundreds of organizations across the country with its on-demand, scheduled services, and Inpathy divisions. "
target: Regroup Telehealth Inc.
Regroup provides customized telepsychiatry solutions, technology, and support teams that contribute to the seamless integration of behavioral health clinicians at partner care sites. Their clinicians collaborate with onsite care teams on patient care plans and workflows for better behavioral care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/23/2019 via MSNBC

Amazon.com, Inc., acquired Health Navigator

synopsis: Amazon, a company that strives to be Earth's most customer-centric company where people can find and discover virtually anything they want to buy online, acquired Health Navigator, a company that provides evidence-based digital health information content that advances patient and provider experience.
buyer: Amazon.com, Inc. (AMZN:$469,822.00)
Amazon strives to be Earth's most customer-centric company where people can find and discover virtually anything they want to buy online. By giving customers more of what they want—low prices, vast selection, and convenience—Amazon continues to grow and evolve as a world-class e-commerce platform. "
target: Health Navigator
Health Navigator provides evidence-based digital health information content that advances patient and provider experience. It works with partners to provide tools that help with remote diagnoses, helping patients figure out whether to stay at home, see a doctor or go straight to the emergency room.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/7/2022 via BNC Analysis

PanGenomic Health Inc., will acquire Mindleap Health

synopsis: PanGenomic Health Inc., a digital health platform in Canada, will acquire Mindleap Health Inc. from Mydecine Innovations Group Inc., a biotechnology company. Mindleap is a telehealth solution that helps people connect with mental health specialists. The app helps people to sleep better, feel safe, and understand psychedelic experiences.
buyer: PanGenomic Health Inc. (CNSX:NARA:$0.00)
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. "
target parent: Mydecine
target: Mindleap Health
Mindleap is a telehealth solution that helps people connect with mental health specialists. Mindleap helps people to sleep better, feel safe, and understand psychedelic experiences. The app allows users to talk to specialists that break down information into useful and digestible segments.
price ($mm)
$3.08
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via GlobeNewswire

Patient Access Solutions, Inc., acquired Tela Mental Health

synopsis: Patient Access Solutions (PASO), a provider of healthcare/financial processing and management solutions for the healthcare industry, has acquired Tela Mental Health. This acquisition will allow PASO to offer mental health services through the telamentalhealth.com portal, connecting patients to psychologists, psychiatrists and therapists nationwide.
buyer parent: Global Energy Resources, Inc
buyer: Patient Access Solutions, Inc. (OTCPK:PASO:$1.82)
Patient Access Solutions Inc. is a Healthcare Solutions company with its sights set on shaking up a stodgy healthcare information technology industry. Paying little respect to tradition in a business rooted in tradition, PASHealth has created a formidable array of technologyand resources. "
target: Tela Mental Health
Tela Mental Health is an American healthcare institution, specializing in mental health. Tela Mental Health is focused on mental wellness for patients accessing their care provider remotely and the demand for this is high.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2022 via PR Newswire

Quip NYC, Inc., acquired Toothpic App

synopsis: quip has acquired Toothpic, a leading telehealth company offering teledental services and care to more than 36 million Americans through partnerships with premier dental insurers. The acquisition makes quip the first oral care company to connect at-home oral care products with preventative telehealth services and professional dental care.
buyer: Quip NYC, Inc.
quip is a modern oral health company that provides thoughtfully designed personal oral care products and professional dental care services through a digital platform that makes oral care more simple, accessible, and enjoyable. "
target: Toothpic App
Toothpic is a leading smart dental technology company on a mission to radically transform people's oral health. Toothpic leverages technology, data and insights to deliver better care, better outcomes and a more personalized experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2020 via GlobeNewswire

CLARITAS HealthTech Pte. Ltd, acquired Integrated Health Ventures Pte Ltd

synopsis: Singapore-based Claritas HealthTech Pte. Ltd., is acquiring Integrated Health Ventures Pte Ltd (IHV) in Singapore and its company in India. IHV has an extensive network of hundreds of hospital and diagnostic center clients for their proprietary teleradiology platform in several developing regions including, South Asia and Africa.
buyer: CLARITAS HealthTech Pte. Ltd
Claritas is incorporated and headquartered in Singapore. Claritas conducts research and development in the fields of image enhancement, machine vision and artificial intelligence (“AI”) with a focus on medical image processing and AI assisted interpretation. "
target: Integrated Health Ventures Pte Ltd
IHV ("Integrated Health Ventures") is headquartered in Singapore, with a development center in Chennai, India. For over a decade, the company has provided teleradiology platforms with low bandwidth optimised and secure clinical systems for hundreds of hospitals and radiology centers globally.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2017 via BNC Analysis

Cannabis Sativa, Inc., acquired PrestoDoctor

synopsis: Cannabis Sativa. Inc., a company that develops and promotes natural cannabis products, has acquired a 51% stake in PrestoCorp (a.k.a. PrestoDoctor), an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology.
buyer: Cannabis Sativa, Inc. (OTCPK:CBDS:$0.03)
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. "
target: PrestoDoctor
PrestoDoctor is an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology. Appointments are 10-15 minutes long, and can be scheduled and completed in the same day.
price ($mm)
$2.39*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like MedAware Systems, Inc.


read more

MedAware Systems, Inc.

Avalere Health LLC

Decision Resources, Inc.

Decision Resources, Inc.

System Analytic Ltd.

Medical Collective Intelligence Co. Ltd.

HealthiVibe LLC

CenterWatch, Inc.

ERT

ERT

CenterWatch, Inc.

CenterWatch, Inc.

Advarra

BresMed Health Solutions Ltd

MedicalDirector

Dymaxium, Inc.

Vidal Group

MedicalDirector

Decision Resources Group

Edital

read more

MedAware Systems, Inc.

read more

MedAware Systems, Inc.

read more

StudyKIK

FourteenFish Ltd

Carepointe

Regroup Telehealth Inc.

Health Navigator

Mindleap Health

Tela Mental Health

Toothpic App

Integrated Health Ventures Pte Ltd

PrestoDoctor

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2021
rev ($mm)
$1,724.14
EBITDA ($mm)
$657.72
EBIT ($mm)
$604.18
Net Income ($mm)
$581.12
Employees
8249
  • drill down
  • watch
Ticker: PFE
 
 
 
 
 
 
 
 
Pfizer, Inc.
Pfizer, Inc.
Pfizer is the world's largest research-based biopharmaceutical company. Pfizer applies science and their global resources to deliver innovative therapies that improve lives. The company has a portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas.
year
2022
rev ($mm)
$81,288.00
EBITDA ($mm)
$30,793.00
EBIT ($mm)
$25,602.00
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: BSE:531637
 
 
 
 
 
 
 
 
Sword and Shield Pharma Ltd.
Sword and Shield Pharma Ltd.
Sword & Shield Pharma is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. They offer a portfolio of products including Active Pharmaceutical Ingredients, generics, differentiated formulations and News Chemical Entities.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: PGNX
 
 
 
 
 
 
 
 
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer.
year
2015
rev ($mm)
$43.27
EBITDA ($mm)
($0.54)
EBIT ($mm)
($1.07)
Net Income ($mm)
$2.85
Employees
57
  • drill down
  • watch
Ticker: ZTS
 
 
 
 
 
 
 
 
Zoetis
Zoetis
Zoetis is a global animal health company. Zoetis develops, manufactures and commercializes medicines, vaccines and diagnostic products. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals.
year
2019
rev ($mm)
$6,260.00
EBITDA ($mm)
$2,578.00
EBIT ($mm)
$2,193.00
Net Income ($mm)
$1,500.00
Employees
10600
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker: CNSX:NF
 
 
 
 
 
 
 
 
Mydecine
Mydecine
Mydecine is a biotechnology company. Mydecine is developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder. They aim to provide patients with safer and more effective treatment solutions.
year
2019
rev ($mm)
$0.18
EBITDA ($mm)
($3.31)
EBIT ($mm)
($3.35)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: EXAS
 
 
 
 
 
 
 
 
Exact Sciences
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. Exact Sciences develops diagnostic tests for several types of cancer. Its flagship product is Cologuard, a stool-based DNA test for colorectal cancer.
year
2017
rev ($mm)
$213.82
EBITDA ($mm)
($118.76)
EBIT ($mm)
($133.03)
Net Income ($mm)
Employees
736
  • drill down
  • watch